Ensofy (Tbilisi, Georgia) – Led by experienced AI and healthtech founders, Ensofy has developed VoiceAI, an AI-enabled screening and monitoring tool for major depressive disorder (MDD). VoiceAI requires 30 seconds of free-form speech to assess depression with demonstrated diagnostic accuracy rates of up to 80%, supporting clinicians and caretakers in mental health management decisions.
